BDBS-12 Reduce the number of persons who develop venous thromboembolism (VTE)

National Data Source
National Ambulatory Medical Care Survey (NAMCS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
National Hospital Ambulatory Medical Care Survey (NHAMCS)
Changed Since the Healthy People 2020 Launch
per 10,000 (age adjusted—see Comments)
Baseline (Year)
54.3 (2007)
Target-Setting Method
10 percent improvement
Number of ambulatory medical care visits with diagnosis of VTE (ICD-9-CM codes 415.1, 451.11, 451.19, 451.2, 451.81, 451.9, 453.1, 453.4, 453.40, 453.41, 453.42, 453.9, 671.3 [0,1,3], 671.4 [0,4], 997.2), in at least one of the three diagnosis fields, during the year of interest, among adults 18 years or older
Number of adults 18 years or older
Data Collection Frequency
Comparable Healthy People 2010 Objective
Not applicable


Methodology Notes

Venous thromboembolism (ICD-9-CM codes, as stated in the definition of numerator) listed in any of the three diagnoses fields, in the mentioned datasets is considered a diagnosis of VTE.

FOR SINGLE DATA YEARS: Ambulatory care visit rates are calculated using the July 1 estimates of the civilian noninstitutionalized population from the Vintage matching the data year for the postcensal period based on the 2000 census. For example, July 1, 2007 civilian noninstitutionalized population estimates from Vintage 2007 are used as the denominator for 2007 rates. Rates for 2010 are also calculated using the July 1 estimates based on the 2000 census.

Age Adjustment

This Indicator uses Age-Adjustment Groups:

  • Total: 18-44, 45-64, 65-74, 75+

References and More Information

  1. Alpert JS, Dalen JE. Epidemiology and natural history of venous thromboembolism. Prog Cardiovasc Dis. 1994;36:417-22.
  2. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ. 2003 Feb 21;52(2):1-8.
  3. MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S5-15. 4.